People with hepatitis B or C are at greater risk for liver cancer, but a low-dose aspirin a day might significantly lower that risk, a new study suggests. Over a median of nearly eight years of follow-up, 4% of those taking low-dose aspirin developed liver cancer, compared with 8.3% of those not taking the drug, […]
